MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1245/s10434-019-07626-y

Медицинская библиотека · Annals of surgical oncology · 2019

Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.

Zaidi Mohammad Y, Lee Rachel M, Gamboa Adriana C, Speegle Shelby, Cloyd Jordan M, Kimbrough Charles, Grotz Travis, Leiting Jennifer, Fournier Keith, Lee Andrew J, Dineen Sean, Dessureault Sophie, Kelly Kaitlyn J, Kotha Nikhil V, Clarke Callisia, Gamblin T Clark, Patel Sameer H, Lee Tiffany C, Hendrix Ryan J, Lambert Laura, Ronnekleiv-Kelly Sean, Pokrzywa Courtney, Blakely Andrew M, Lee Byrne, Johnston Fabian M, Fackche Nadege, Russell Maria C, Maithel Shishir K, Staley Charles A

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

For patients with peritoneal carcinomatosis undergoing cytoreductive surgery with heated intraperitoneal chemotherapy (CRS/HIPEC), incomplete cytoreduction (CCR2/3) confers morbidity without survival benefit. The aim of this study is to identify preoperative factors which predict CCR2/3.

METHODS

All patients who underwent curative-intent CRS/HIPEC of low/high-grade appendiceal, colorectal, or peritoneal mesothelioma cancers in the 12-institution US HIPEC Collaborative from 2000 to 2017 were included (n = 2027). The primary aim is to create an incomplete-cytoreduction risk score (ICRS) to predict CCR2/3 CRS utilizing preoperative data. ICRS was created from a randomly selected cohort of 50% of patients (derivation cohort) and verified on the remaining patients (validation cohort).

RESULTS

Within our derivation cohort (n = 998), histology was low-grade appendiceal neoplasms in 30%, high-grade appendiceal tumor in 41%, colorectal tumor in 22%, and peritoneal mesothelioma in 8%. CCR0/1 was achieved in 816 patients and CCR 2/3 in 116 patients. On multivariable analysis, preoperative factors associated with incomplete cytoreduction were male gender [odds ratio (OR) 3.4, p = 0.007], presence of ascites (OR 2.8, p = 0.028), cancer antigen (CA)-125 ≥ 40 U/mL (OR 3.4, p = 0.012), and carcinoembryonic antigen (CEA) ≥ 4.2 ng/mL (OR 3.2, p = 0.029). Each preoperative factor was assigned a score of 0 or 1 to form an ICRS from 0 to 4. Scores were grouped as zero (0), low (1-2), or high (3-4). Incidence of CCR2/3 progressively increased by risk group from 1.6% in zero to 13% in low and 39% in high. When ICRS was applied to the validation cohort (n = 1029), this relationship was maintained.

CONCLUSION

The incomplete cytoreduction risk score incorporates preoperative factors to accurately stratify the risk of CCR2/3 resection in CRS/HIPEC. This score should not be used in isolation, however, to exclude patients from surgery.

Для цитирования: Zaidi Mohammad Y, Lee Rachel M, Gamboa Adriana C, Speegle Shelby, Cloyd Jordan M, Kimbrough Charles, Grotz Travis, Leiting Jennifer, Fournier Keith, Lee Andrew J, Dineen Sean, Dessureault Sophie, Kelly Kaitlyn J, Kotha Nikhil V, Clarke Callisia, Gamblin T Clark, Patel Sameer H, Lee Tiffany C, Hendrix Ryan J, Lambert Laura, Ronnekleiv-Kelly Sean, Pokrzywa Courtney, Blakely Andrew M, Lee Byrne, Johnston Fabian M, Fackche Nadege, Russell Maria C, Maithel Shishir K, Staley Charles A. Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.. Annals of surgical oncology. 2019. DOI: 10.1245/s10434-019-07626-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.